News of 25-year patent term is premature, but expect big pharma changes in China in the near future
Headlines were generated earlier this week, following a report that China has introduced 25-year patent terms for some innovative drugs. However, it turns out not to be true, with a number of sources confirming that no such changes have yet been…
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.